Top Story

Weekly prophylaxis with nonacog beta pegol safe, effective for hemophilia B

October 31, 2014

Nonacog beta pegol effectively treated bleeding episodes and was associated with low annualized bleeding rates in patients with hemophilia B, according to study results.

Peter W. Collins, MD, of the Arthur Bloom Hemophilia Center at Cardiff University in the United Kingdom, and colleagues sought to evaluate the safety and efficacy of nonacog beta pegol (N9-GP, Novo Nordisk) — a recombinant glycoPEGylated Factor IX with an extended half-life — in 74 previously treated patients with hemophilia B.

figure Video

CTL019 therapy induced sustained remission in relapsed, refractory ALL

October 30, 2014
PHILADELPHIA — David L. Porter, MD, director of blood and marrow transplantation at Abramson Cancer Center at the University of Pennsylvania, discusses study…
Worth Building

Question your allocation to deal with recent stock market volatility

October 30, 2014
The summer stock market doldrums have morphed into a high octane volatile zig-zag. So I ask you – what is new? Haven’t we been here before? The trouble is…
Meeting News Coverage

Gender, lymph node ratio linked to papillary thyroid carcinoma recurrence

October 30, 2014
CORONADO, Calif. — Elevated lymph node ratio and male gender were strongly associated with poorer disease-free survival among patients with papillary thyroid…
More News Headlines »
CME
figure

Targeted Therapy and Immunotherapy in the Management of Metastatic Melanoma: 2014 Updates - Monograph

Melanoma remains a challenging condition for clinicians. An array of targeted therapies and immunotherapy are in…
More »
Video
figure

CTL019 therapy induced sustained remission in relapsed, refractory ALL

October 30, 2014
PHILADELPHIA — David L. Porter, MD, director of blood and marrow transplantation at Abramson Cancer Center at…
More »
CME
figure

New Advances, New Options: Evaluating the Changing Landscape of Hemophilia to Optimize Patient Outcomes

This activity is supported by an educational grant from Biogen Idec.

The bleeding abnormalities associated with hemophilia can have devastating consequences for patients. Recent advances…
More »